Vividion Therapeutics
Phase 1We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with devastating diseases not
Founded
2013
Focus
Small Molecules
About
We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with devastating diseases not
Funding History
3Total raised: $267M
Series C$135MSoftBank Vision Fund 2Aug 15, 2021
Series B$82MBayerJan 15, 2020
Series A$50MARCH Venture PartnersAug 15, 2017
Company Info
TypePrivate
Founded2013
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile